[Hereditary optic atrophies].

Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science (1988) 11.76

Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet (2000) 7.40

OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet (2000) 7.20

Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res (2004) 3.75

OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain (2007) 3.35

The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain (1995) 2.94

Leber hereditary optic neuropathy: identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet (1991) 2.70

The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet (2002) 2.67

The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation. Am J Ophthalmol (1991) 2.57

An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun (1992) 2.43

Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet (1995) 2.17

Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology (2005) 2.01

Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol (1998) 1.93

Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation. Arch Ophthalmol (1993) 1.93

Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology (2008) 1.78

Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Suppl (1959) 1.72

Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology (1996) 1.71

Disc excavation in dominant optic atrophy: differentiation from normal tension glaucoma. Ophthalmology (2001) 1.60

Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet (2001) 1.56

The inheritance of Leber's disease. A genealogical follow-up study. Acta Ophthalmol (Copenh) (1985) 1.55

Heteroplasmy in Leber's hereditary optic neuropathy. Arch Ophthalmol (1993) 1.51

Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand (1996) 1.50

Cytochrome c release from mitochondria: all or nothing. Nat Cell Biol (2000) 1.47

Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy. Acta Ophthalmol (Copenh) (1983) 1.46

OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet (2004) 1.42

Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol (2004) 1.40

OPA1-associated disorders: phenotypes and pathophysiology. Int J Biochem Cell Biol (2009) 1.40

Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol (1993) 1.38

Leber's hereditary optic neuropathy. Clinical manifestations of the 3460 mutation. Arch Ophthalmol (1992) 1.37

Dominant optic atrophy. The clinical profile. Arch Ophthalmol (1979) 1.34

A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol (2000) 1.28

Prophylaxis for second eye involvement in leber hereditary optic neuropathy: an open-labeled, nonrandomized multicenter trial of topical brimonidine purite. Am J Ophthalmol (2005) 1.27

Evidence for a novel x-linked modifier locus for leber hereditary optic neuropathy. Ophthalmic Genet (2008) 1.24

Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology (1980) 1.24

Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet (1996) 1.23

Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol (1973) 1.23

The early phase in Leber hereditary optic atrophy. Arch Ophthalmol (1977) 1.23

Hereditary optic neuropathies. Eye (Lond) (2004) 1.23

Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol (2007) 1.19

OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol (2009) 1.19

OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol (2005) 1.18

Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol (2003) 1.17

Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet (2007) 1.14

Pedigree analysis of French Canadian families with T14484C Leber's hereditary optic neuropathy. Neurology (1998) 1.14

Leber's hereditary optic neuropathy with childhood onset. Invest Ophthalmol Vis Sci (2006) 1.14

[Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy]. Arch Soc Esp Oftalmol (2007) 1.13

Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr (1994) 1.11

Diagnostic criteria in cominantly inherited juvenile optic atrophy. A report of three new families. Am J Optom Arch Am Acad Optom (1972) 1.10

Genetic heterogeneity of dominant optic atrophy, Kjer type: Identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol (1999) 1.08

A familial syndrome of infantile optic atrophy, movement disorder, and spastic paraplegia. Neurology (1989) 1.08

Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network. Invest Ophthalmol Vis Sci (2005) 1.06

Hereditary optic atrophy with dominant transmission; three Danish families. Acta Ophthalmol (Copenh) (1950) 1.04

The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyes. Eye (Lond) (1997) 1.00

Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthalmol (2004) 1.00

Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study. Trans Am Ophthalmol Soc (2006) 1.00

Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat (2003) 0.99

Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy. Invest Ophthalmol Vis Sci (2008) 0.98

A third locus for dominant optic atrophy on chromosome 22q. J Med Genet (2005) 0.98

Hereditary infantile optic atrophy with dominant transmission; preliminary report. Dan Med Bull (1956) 0.97

Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON). Neurobiol Dis (2006) 0.95

Regulation of DNA-dependent protein kinase activity by ionizing radiation-activated abl kinase is an ATM-dependent process. J Biol Chem (2000) 0.94

Reversible optic neuropathy with OPA1 exon 5b mutation. Ann Neurol (2008) 0.93

A first locus for isolated autosomal recessive optic atrophy (ROA1) maps to chromosome 8q. Eur J Hum Genet (2003) 0.92

Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation. Am J Med Genet A (2005) 0.91

Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter. Doc Ophthalmol (1999) 0.89

Psychophysical and visual evoked potential findings in hereditary optic atrophy. Trans Ophthalmol Soc U K (1979) 0.88

Dominant hereditary optic atrophy with bitemporal field defects. AMA Arch Ophthalmol (1958) 0.87

Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome. J Med Genet (1996) 0.87

A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome. Am J Hum Genet (1997) 0.86

Color vision in dominant optic atrophy. J Clin Neuroophthalmol (1992) 0.85

Dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy. A new syndrome. Ophthalmology (1984) 0.85

Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect. Mol Vis (2009) 0.82

Woman with atypical unilateral Leber's hereditary optic neuropathy with visual improvement. Clin Experiment Ophthalmol (2007) 0.82

Short wavelength-automated perimetry compared with standard achromatic perimetry in autosomal dominant optic atrophy. Br J Ophthalmol (2006) 0.82

Dominant congenital deafness and progressive optic nerve atrophy. Occurrence in four generations of a family. Arch Ophthalmol (1974) 0.80

A family with apparently sex-linked optic atrophy. J Med Genet (1975) 0.80

Types of acquired colour deficiencies caused by autosomal-dominant infantile optic atrophy. Mod Probl Ophthalmol (1972) 0.79

[On a heredo-familial disease combining cataract, optic atrophy, extrapyramidal symptoms and certain defects of Friedreich's disease. (Its nosological position in relation to the Behr's syndrome, the Marinesco-Sjogren syndrome and Friedreich's disease with ocular symptoms]. Rev Neurol (Paris) (1961) 0.79

A family with X-linked optic atrophy linked to the OPA2 locus Xp11.4-Xp11.2. Am J Med Genet A (2006) 0.79

Cardiac abnormalities in patients with Leber's hereditary optic neuropathy. Heart (2003) 0.77

Electrophysiological discrimination between retinal and optic nerve disorders. Metab Pediatr Syst Ophthalmol (1985) (1989) 0.77

Electrophysiology and colour perimetry in dominant infantile optic atrophy. Br J Ophthalmol (1991) 0.76

A mathematical description of nerve fiber bundle trajectories and their variability in the human retina. Vision Res (2009) 1.39

VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity. Br J Ophthalmol (2008) 0.96

[Pathogenesis of retinopathy of prematurity]. Ophthalmologe (2012) 0.86

Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol (2000) 0.86

The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Graefes Arch Clin Exp Ophthalmol (2008) 0.84

Influence of narcotics on luminance and frequency modulated visual evoked potentials in rats. Doc Ophthalmol (2009) 0.84

[Congenital cranial dysinnervation disorders]. Ophthalmologe (2007) 0.82

["Fragebogen zum Kindlichen Sehvermögen (FKS)". Assessment of quality of life with the German version of the Children's Visual Function Questionnaire]. Ophthalmologe (2009) 0.81

[Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression]. Ophthalmologe (2010) 0.81

[Clinical and neuroradiological diagnostics of orbital tumors]. Ophthalmologe (2011) 0.80

[Oculomotor, trochlear, and abducens nerve palsies]. Ophthalmologe (2007) 0.79

[The treatment of congenital cataract in Germany--results of a survey]. Klin Monbl Augenheilkd (2008) 0.78

[Results of pars plana lensectomy for childhood cataract]. Ophthalmologe (2004) 0.77

[Pharmacological treatment of nystagmus]. Ophthalmologe (2011) 0.77

Gabapentin-lactam (8-aza-spiro[5,4]decan-9-on; GBP-L) inhibits oxygen glucose deprivation-induced [3H]glutmate release and is a neuroprotective agent in amodel of acute retinal ischemia. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.76

[Eye motion impairment and optic nerve atrophy. A 1-year-old patient with vertical gaze paresis and bilateral optic nerve atrophy]. Ophthalmologe (2004) 0.75

[Current recommendations on optic neuritis]. Ophthalmologe (2014) 0.75

[Drug therapy and radiotherapy in Graves' orbitopathy]. Ophthalmologe (2011) 0.75

[Spontaneous intraorbital haemorrhage]. Klin Monbl Augenheilkd (2013) 0.75

[Cotton wool spots in a 16-year-old girl]. Ophthalmologe (2005) 0.75

[Clinical and neuroradiological diagnostics in Graves' orbitopathy]. Ophthalmologe (2011) 0.75

[Neuroprotection. Bases and possibilities of a future clinical use]. Ophthalmologe (2001) 0.75

[Visual field defects after epilepsy surgery: implications for driving license tenure]. Ophthalmologe (2014) 0.75

[Prevalence of glaucoma in obstructive sleep apnea]. Ophthalmologe (2015) 0.75

[Psychometric properties of the FKS : Reliability, validity, Rasch analysis, and descriptive results of the German version of the Children's Visual Function Questionnaire]. Ophthalmologe (2011) 0.75

[The effect of gabapentin and gabapentin-lactam on retinal ganglion cell survival. Situation after acute retinal ischemia in animal models]. Ophthalmologe (2001) 0.75

[Function-retaining reconstruction after orbital trauma]. Ophthalmologe (2011) 0.75

[Episodic progressive bilateral visual deterioration]. Ophthalmologe (2008) 0.75

[A critical view of alternative methods for treating visual complaints]. Ophthalmologe (2008) 0.75